Objective: to identify the different types of morphological alterations from lipodystrophy syndrome (LS) in outpatients and relate them to the therapeutic regimen used. Method: a cross-sectional study which recruited 60 patients with HIV and LS and 79 without LS, who consented to interview and data collection from their medical notes. Results: the region most affected by lipoatrophy was the face; by lipohypertrophy, the abdomen, and by the Alteraciones corporales: terapia antirretroviral y síndrome de la lipodistrofia en personas que viven con VIH/SIDA Objetivo: identificar los diferentes tipos de alteraciones morfológicas del Síndrome de la lipodistrofia (SL) en pacientes de los servicios de ambulatorio y relacionarlas al esquema terapéutico utilizado. Método: estudio transversal en lo que fueron reclutados 60 pacientes con VIH y la SL y 79 sin la SL, que consintieron entrevista y recogida de datos en prontuario. Resultados: la región más acometida por la lipoatrofia fue la cara; por la lipohipertrofia el Abdomen y por la forma mixta las alteraciones en Abdomen, cara, miembros superiores e inferiores. Conclusión: entre los esquemas terapéuticos, el compuesto por la zidovudina, lamivudina y efavirenz pareció proteger contra la SL.
Introduction
Inhibitors (NARTI) and the Protease Inhibitors (PI) (1) (2) .
It is characterized principally by alterations in the distribution of body fat, such as the loss of peripheral subcutaneous tissue and increase of central fat, and by metabolic disorders such as dyslipidemia, insulin resistance and abnormal glucose homeostasis, which may contribute to the development of cardiovascular illnesses and diabetes mellitus (3) (4) . hump" (5) (6) .
Morphological
Fat loss and accumulation can occur simultaneously -in different regions of the body -in the same individual. This is called the mixed form. About 50% of the patients receiving antiretroviral therapy are affected by body changes resulting from LS (7) (8) . Among Brazilian patients, the prevalence described was of 55% (9) . Despite the great success of drug therapy in reducing the patients' morbidity and mortality rates (10) , the effects of LS -in particular, those which cause alterations in body image -contribute to the appearance of stigma, problems in social activities and alterations in sexuality, among others, impacting on quality of life (11) (12) .
Nursing has been developing various studies concerning the effects of LS on patients, from identifying their perceptions about changes in appearance (13) , to testing interventions which help them to face these (14) . The periodicals in the area, however, do not provide detailed evidence on discriminating between the morphological abnormalities by anatomical region, correlated with the ARVT used. Providing nursing care for the HIV patient requires varying skills of health professionals, as they are dealing with a client group which presents a range of simultaneous needs. Particularly in relation to drug therapy, the nurse has the mission of informing the client about its benefits and the need for good compliance, as well as the possible side-effects and ways of controlling them, such that the patient feels safe in undergoing the treatment (15) .
Thus, this study aimed to identify the different types of morphological alterations from LS present in outpatients and relate them to the therapeutic regimen being used, so as to provide support for nursing professionals to be able to promote specialized care for this population's needs.
Method
This is a cross-sectional, comparative, descriptive study, carried out through a questionnaire with 14 closed questions, which included demographic data, current conditions of opportunistic infection, the case history of the HIV infection, ARV medication being used, and clinic-laboratory and somatometric data. 
Statistical analysis
The results were analyzed using Fisher's exact test, with the help of the GraphPad InStat 3.01 program.
Associations with a probability of below 5% (p<0.05) were considered.
Results
Of the 60 patients with LS selected for the study, 40 (67%) were male and 20 (33%) female; 45 (75%)
were Caucasian, 08 (13.33%) were Afro-Brazilian and 7 (11.66%) were mixed-race. The participants' average age was 43.08±7. Table 1 .
In the analysis of the most-affected body regions, the researchers verified the therapeutic regimens used. Table 3 shows the comparison of the therapeutic regimens most used by the patients with and without LS. Statistically-significant data is in bold type. Statistically-significant data is in bold type. 
Discussion
The pathogenicity of LS has been under study for over 10 years, and various factors have been identified as contributing to its development, such as gender, age, duration and seriousness of infection with HIV-1 (2, 16) , and the use of antiretroviral therapy (1) (2) , in addition to the influence of the inflammatory cytokine genes in patients with LS on ARVT (17) .
Of the alterations caused by LS, those which cause great difficulties for the patients are the alterations in body harmony negatively impacting on their daily activities (11) . In our study, the morphological abnormalities were described in 23 patients (38.33%) in the form of lipoatrophy, in 9 (15%) as signs of fat accumulation, and 28 patients (46.66%) in the mixed form. These prevalencies are close to a description which evaluated a sample of 1,348 patients (8) .
Lipoatrophy has been showed to be more frequent than lipohypertrophy (18) and the face is the mostaffected body region, followed by the lower limbs, the buttocks, and the upper limbs (18) . In the present study's stratification, the face was the most-affected region, although the authors did not identify differences of prevalence between the upper limbs (MMSS) and the lower limbs (MMII), neither lipoatrophy exclusive to the buttocks, which was only perceived in the mixed form of LS. In relation to lipohypertrophy, the abdomen was the most-affected body region, in line with other studies (2, 8) , followed by the breast, dorsocervical region and thorax.
The most found mixed form was shown by the presence of lipohypertrophy of the abdomen and atrophy of the face, upper limbs and lower limbs.
Retroviral drugs' association with LS is incontestable and was described a long time ago. In view of this, an analysis was undertaken of the therapeutic combinations most used by the two groups of patients studied -with and without LS (Table 3) . Thus, the therapeutic regimen made up by the combination of Zidovudine + Lamivudine + Efavirenz (AZT + 3TC + EFZ) was shown to be a protector against LS (p=0.0149). A study carried out with 100 patients who received this same therapeutic combination for 48 weeks and who were later evaluated using imaging exams -computerized tomography and DEXA -dual X-ray absorptiometry -confirms that this therapeutic regimen is not associated with significant morphological changes, as it resulted in a minimal and modest fat accumulation (19) .
The influence of NARTI class medications in the development of LS is predominantly reported through the use of Stavudine (d4T) (20) and of AZT, in lower intensity (21) .
When the authors analyzed each antiretroviral drug in isolation (Table 4) , two drugs from the NARTI class -AZT and Lamivudine (3TC) -seemed to suggest protection against the development of LS (p<0.0001 and p=0.0103, respectively). However, the authors emphasize that a better investigation is necessary, including a thorough analysis of the therapeutic combinations used. In addition, consistent information was not found on the influence of 3TC on its own in the development of LS. Furthermore, there is a report of the combination of these two drugs in the development of morphological changes (22) .
According to the present study's data, a further two drugs in this class -Tenofovir (TDF) and Didanosine (ddI)
seem to contribute to the development of LS (p=0.0427 and p=0.0432, respectively). The information on the role of ddI in LS are conflicting: one study states that this drug is independently associated with LS (23) and
another, that the use of ddI is significantly associated with the depletion of mitochondrial DNA in the adipose tissue of patients with peripheral lipoatrophy, and that this may be reverted with discontinuation of use (24) . However, another study states that ddI does not contribute to peripheral lipoatrophy (25) . In relation to TDF, in contrast to what the present study's authors found, it seems there is a consensus in the literature that the substitution of d4T with TDF minimizes the risk of developing LS (20) , improving the recuperation of peripheral adipose tissue and in this way contributing to the reversal of lipoatrophy (26) .
Despite the PI class being widely related to LS (5) , the authors did not determine influences of these medications in the present study. 
Conclusion
With this study, the authors conclude that the region most affected by lipoatrophy was the face, 
